You're contacting media contact of this press release

Title: GLP-1 News Today Highlights CoreAge Rx for Complete Price Transparency in Telehealth Industry

United States, 30th Jan 2026 – GLP-1 News Today, a trusted source for coverage and comparative analysis of GLP-1 weight management treatments, has released new findings highlighting CoreAge Rx as the top-ranked provider for price transparency among more than 12 online tirzepatide and semaglutide providers reviewed. The analysis confirms that CoreAge Rx stands out in an increasingly crowded telehealth market by offering clear, all-inclusive pricing with zero hidden fees, earning the platform its #1 ranking.According to GLP-1 News Today’s latest comparative report, many telehealth providers promoting GLP-1 medications advertise low starting prices that appear attractive at first glance. However, deeper evaluation reveals that these prices often exclude essential costs such as medical consultations, shipping, and monthly membership or program fees. These additional charges can significantly increase the total monthly expense for patients, creating confusion and frustration for consumers seeking affordable and predictable care.In contrast, GLP-1 News Today confirms that CoreAge Rx’s pricing model is fully transparent and upfront. Patients pay $149 per month for tirzepatide and $99 per month for semaglutide, with these prices already including medical consultation, prescribed medication, and free 2-day shipping. There are no surprise add-ons, no mandatory memberships, and no hidden service charges added later in the checkout process.“Price transparency is one of the most important factors for patients exploring GLP-1 medications online,” said Jenny Thornton, spokesperson for GLP-1 News Today. “Our analysis shows that CoreAge Rx clearly communicates its total monthly cost upfront, which is not common in this space. That level of honesty...

This press release is issued by King Newswire